Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Earnings call · FY2026 Q3
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio, 6-K call announcement stay in one workspace.
Management tone
Positive
Net tone +45 · moderate hedging
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
Hello, ladies and gentlemen. Thank you for standing by for RLX Technology Inc.'s third quarter 2026 earnings conference call. At this time, all participants are in listen-only mode. After management's remarks, there will be a question and answer session. Today's conference call is being recorded and is expected to last for about 30 minutes. I will now turn the call over to your host, Mr. Sam Tsang, Head of Capital Markets for the company. Please go ahead, Sam.
Thank you very much. Hello, everyone, and welcome to Irish Technologies' third quarter 2026 earnings conference call. The company's financial and operational results were released through PR Newswire earlier today and have been made available online. You can also view the earnings press release by visiting our IR website at ir.resistab.com. Participants on today's call will include our Chief Financial Officer, Mr. Chow Lu, and me, Sam Tseng, Head of Capital Markets. Before we continue, please note that today's discussion will contain forward-looking information made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements typically contain words such as may, will, expect, anticipate, aim, estimate, intent, plan, belief, potential, continue, or other similar expressions. Board-looking statements involve inherent risks and uncertainties. The accuracy of these statements may be impacted by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Many of which are factors beyond our control. The companies and its affiliates, advisors, and representatives do not undertake any obligation to update these foreign-looking information, except as required under the ethical law. Please note that RX Technologies earnings press release and this conference call include discussions of an audited gap financial measures As well as unaudited non-GAAP financial measures. Our Express release contains a reconciliation of the unaudited non-GAAP measures to the unaudited GAAP measures. In today's call, management will use English as the main language. We will also provide simultaneous interpretation on the Chinese line. Please note that the Chinese line is in listen-only mode, and Chinese interpretation is for convenience purpose only. In case of any discrepancy, management statements in the original language will prevail. I will now turn the call over to Mr. Chao Lu. Please go ahead.
Thank you, Sam, and hello, everyone. The third quarter marked an inflection point for ILX. We have updated you on the building blocks of our growth strategy, bringing our Shenzhen Nexus hub into full operation, growing our smoke-free product portfolio, broadening our international footprint, and building our route to market with strategic investments in Europe. This quarter, these initiatives We came together as one for the first time. And supply chain capabilities with local distribution. $1.92 billion, our highest quarterly total. 9.7% year-over-year and 89.7% quarter-over-quarter. International business accounted for 86.5% of total net revenue. This is primarily driven by the consolidation of our newly acquired Western We are operating as the leading global smoke-free brand, anchored in adult consumer trust while backed by end-to-end capabilities across product innovation, supply chain execution, and direct In our markets, adult consumers and retail partners increasingly recognize our brands for regulatory compliance, professional innovation, and uncompromising product quality. Having direct connection to over 30,000 physical retail endpoints and a proprietary B2B ordering platform connecting more than 20,000 independent merchants gives us a clear, first-hand understanding of what retailers need and what products actually drive sales. We recognize that while distributors effectively and efficiently move boxes, sustaining brand velocity requires active on-the-ground consumer pool. And with these deeper retail insights, we are doubling down on localized commercial execution across Europe. I'm finishing local offices and deploying dedicated field sales teams on the road. Expand shelf space and accelerate point-of-cell turnovers. directly with our R&D center to tailor flavor profiles, device specifications, and packaging to match the distinct consumer preferences and regulatory nuances. While maintaining the reach, speed, and adjustment. Global Standard Shenzhen Speed Approach. As regulatory oversight tightens across international markets, with the UK's excise duty taking effect in October and heightened European scrutiny over product standards, meeting global standards is non-negotiable. Our laboratories And specialized research centers hold every formulation and device. To farmer-grade standards from data. Thank you very much for the collaboration between our front-line market teams and our back-end team. and regulatory updates from local markets straight into our Shenzhen Nexus Hub, which integrates We're going to launch cycles for months. with market demand. Our integration philosophy centers on empowerment. We continue to operate as an open, multi-brand marketplace to preserve retail trust. Supply Chain Scale and Financial Resources to Lower Procurement and Logistics Great product portfolio. We have commercialized our modern oral nicotine pouch line, and are actively In other next-generation product sectors, we also hold proprietary technology, an extensive patent portfolio, and market-ready products poised for life. It helped review of our third quarter financial performance. This increased 26.7% year-over-year and 24.8% sequentially to RMB 446.6 million. An expected normalization reflecting the structural shift in our business mix following the July consolidation. Inherently operate at a lower growth margin than branded products, while significantly expanding our absolute growth profit base. Empowering our distribution business' growth margin through the deployment of additional capital and supply chain optimization. The call was $7.1 million compared with RMB $259.3 million in the same period of 2025, primarily attributable to higher salary and welfare expenses as we expanded local teams in international markets and consolidated the workforce. As well as Non-GAAP operating and net income. Non-GAAP income from operations was RMB 143.8 million, and non-GAAP net income enriched RMB 235.6 million, underscoring the resilience of our underlying operations. Acquisition added a substantial distribution operation and warehouse inventory. We maintained healthy working capital efficiency. Inventory turnover stood at 47 days, accounts receivable turnover at 20 days, and accounts payable turnover at The call is rebounded to RMB 40.0 million, returning to positive territory following an operating cash flow. Absorption. of our revenue coming from international markets this quarter. Our overseas products are sold in US dollars, British pounds, and local currencies at relatively stable local price points. Because Because our reporting currency is in RMB, Again, the RMB directly reduces our translated RMB revenue, while our RMB The planning sheet remains updated. and investments stood at RMB 13. Payout ratio of 100% of non-GAAP net income through regular dividends and ongoing share purchases. Under-capitalized and non-compliant operators to exit the market. Thank you, operator. We are now ready to take questions.
Thank you. We will now begin the question and answer session. To ask a question, you may press star than 1 on your telephone keypad. If your question has already been addressed and you'd like to remove yourself from queue, please press star than 2. We also ask that you please pick up your handset before pressing the keys. For the benefit of all participants on today's call, if you wish to ask your question to management in Chinese, please immediately repeat your question in English. We'll pause for just a moment while we assemble our roster. And today's first question comes from Christine Peng at UBS. Please go ahead.
Thank you, management, for the very detailed explanation for the quarter results. So I have two questions. So the first question is about how does management balance The M&A strategy with the capital allocation strategy, I think that the reason I asked this question was because in the short term, the M&A strategy could depress the earnings, but in the longer term, it could benefit the gross outlook. So I was just wondering how management will balance the short-term impact with the long-term benefits from the shareholders' perspective. So I think that's the first question. The second question is more about the regulation headwind we are seeing in China. So basically, this year, we are seeing Chinese government cancelling the VAT rebates towards the vapor manufacturers. So I was just wondering what the financial impact management have been seeing in this quarter result and what's going to be the outlook going forward. Thank you.
Thank you very much, Christine, for your question. So the first one is about the balance between our M&A strategy and also our shareholder report program. And the second one is about the export rebate, what will happen on our financials. So regarding the first question, I think it's worth noting that our GAAP gross margin in the third quarter was weighted down by a 43.5 million RMB of a one-time non-cash cost of revenues adjustment stemming from the acquisition related to an inventory fare value step up. So, if you look at the gross margin of a non-GAAP basis, which is... Removing this factor is about 25% or more. So while we consolidate a European distribution platform, shifts our headline gross margin percentage, I think it's immediately accretive to absolute profit and expands our earning base. In our capital allocation framework, strategic M&A, share repurchases, and dividends reinforce one each other. Backed by ample cash reserves, that comfortably fund all the priorities. Rather than setting a rigid annual cap of each item, we allocate capital dynamically based on strategic merits, PE accretion, and long-term return on investor capital. Strategic M&A unlocks multi-year synergies and extends our brand reach. Buybacks demonstrate conviction in our long-term intrinsic value, and dividends share profits directly with shareholders. Year-to-date, we have deployed significant capital into structured buybacks through prepaid puts alongside our mid-year European deal. Following year-end settlements, management and the board will evaluate a dividend in the first half of next year. Upholding our commitments to return at least 100% of our non-GAAP net income annually through both dividends and share repurchases. So regarding your second question of the VAT rebates, as you can see, the first quarter infantry pull forward was a brief cycle that concluded cleanly in the third quarter, giving 2021 a clean operating baseline. Across the value chain, adult consumers, brand owners like us, component suppliers, and distribution partners naturally share these adjustments in line with local bargaining power, competitive dynamics, and brand strength. Because we built adequate strategic inventory ahead of these policies and collaborated closely upstream and downstream. The net impact of our core operating margins remains minimal. Having navigated numerous regulatory transitions globally, we paired deep consumer insights with disciplined SKU management, focusing on portfolio on fast-moving, high-demand products with healthy infantry turnover. Looking ahead, we are also expanding our overseas manufacturing to ensure long-term supply chain resilience. Thank you for your question.
Thank you. Our next question today comes from Lydia Ling at Citi.
Please go ahead.
Hi, management. This is Lydia from Citi. So I have two questions. My first question is about international expansion. So with the consolidation of the newly acquired EU entity, so what would be your outlook for the international expansion for 2027? And also, specifically, could you share with us some details in that how you will drive the market share, especially in your market, and also what kind of the challenges that you would anticipate. And my second question is, could you share also your update on the M&A pipeline and also strategic priority? Thank you.
Thanks, Lydia, for our question. So the first one is on the growth trajectory of our company, and the second one is on our M&A pipelines. So if Shenzhen hosting APEC this week, under the themes of openness, innovation, and regional cooperation, the world is seeing firsthand how Shenzhen serves as a premier powerhouse for advanced manufacturing and rapid innovation. So, heading into 2027, our international growth builds directly on this foundation by pairing global-centered Shenzhen Speed product engineering with strong local commercial execution. We are gaining market share by combining trusted brand equity with a deep understanding of local adult consumers, tailoring flavors, device formats, and price architecture to match regional preferences. Alongside our open, multi-brand retail ecosystem, we are scaling next-generation e-vapor devices and modern oral nicotine products built around real-user needs. As global regulations become clearer and more standardized, industry consolidation steadily flavors compliance, innovation-driven, quality-assured public companies like Rx. Regarding our M&A strategies, For the rest of this year or next year, we maintain a robust M&A pipeline centered primarily on Europe, targeting markets with mature regulatory frameworks alongside stable macroeconomic and currency environments. Strategically, we evaluate opportunities across the full value chain, from supply chain opportunities, And brand owners to establish distribution and retail networks that unlock clear commercial synergies. We pair strict valuation discipline with tailored structure, such as stage acquisition, to align long-term incentives and optimize returns. And above all, we prioritize M&A candidates with passionate teams that demonstrate genuine chemistry. And shared culture with Rx. Our philosophy is to preserve their entrepreneurial agility while empowering them with our brand strength, deep user, and product insights, global supply chain scale, and capital resources to accelerate mutual growth. Thank you for your questions.
Thank you. Our next question today comes from Zoe Zhao with CICC. Please go ahead.
This is Zoe from CICC. I have two questions about the international markets. First, as for the Southeast Asia, what is your strategy for the SEA market going forward? And we know that in second quarter, there are some relations. And what's your current situation in this market? And next, about the European market, how's the integration of your European acquisition in July processing? And how is its profitability trending things?
Thank you, Sui, for your questions. So, I mean, across Southeast Asia, RX holds a number one market leadership in multiple key countries, anchored by strong brand equity and deep consumer trust. We see tremendous long-term runway across the region, supported by high adult smoking rates, young demographics, and expanding adoption of next-generation products. Earlier this year, selected local distributors completed isolated working capital adjustments that temporarily moderated ordering space. While underlying consumer demand and brand health remain consistently resilient, we are collaborating closely with our partners to restore normal ordering contents while introducing more agile channel models. Moving forward, our strategy centers on deep local user insights, precise price architecture, and continuous product innovation tailored to each market to reinforce our regional leadership. And regarding our second question of our European acquisition, we completed the financial integration in the third quarter. Seamlessly aligning our newly acquired European platform with public company reporting standards. Operationally, its extensive retail reach gives us real-time visibility into user behavior and shelf space dynamics, sharpening our product strategy and creating a strong launchpad for modern oral nicotine and adjacent categories. Obviously, the border market is navigating the vaping product duty transition window, during which brand partners naturally prioritize customer-based stability as the industry adapts. True to our empowerment philosophy, we support local leadership with trade show visibility, working capital, supply chain scale, and direct brand owner sourcing. As existing infantry cycles, Through on a first-in, first-out basis, we expect these operational synergies to drive meaningful margin expansion next year. Thank you for your questions.
Thank you. And our next question today comes from Yun Guo with CITIC. Please go ahead.
My question is that regarding the EUC's plan to implement an illiquid tax, how do you evaluate the potential impact on both the industry and the company, and what is the company's strategy to navigate this change?
Thank you very much, Guoyun, for your questions. As the vaping prior duty got effective in October this year, there have been a six-month of transitional period from October this year to March next year. We are seeing a growing number of distributors and retailers are increasing their inventory, parallel to the tax. To ensure the price is competitive and the product is competitive. And regarding the duty itself, we view it as a constructive long-term catalyst for the compliance sector. Paired with stronger enforcements with increasing number of offices, the new framework levels the playing field and expands the addressable markets for legitimate operators like our companies. Positioning our UK-established business, including our distribution and retail footprints, to gain more share. The market is currently moving through the transition period, and full pricing and market dynamics should become more visible towards the end of first quarter next year. Financially, the duty passes through into retail pricing. Compliant e-vapor products remain significantly more cost-effective than combustible cigarettes and continue to earn strong adult user loyalty through superior product experiences. Mechanically, passing through the DOT leaves reported revenue while keeping gross profit and unique economics rock solid. Thank you for your question.
Thank you. Due to time constraints, now I would like to turn the call back over to the company for closing remarks.
Thank you once again for joining us today. If you have further questions, please feel free to contact Rx Technologies' Investor Relations team through the contact information provided on our website or reach out to Pierre Chante Financial Communications.
Thank you. This concludes the conference call. You may now disconnect your line. Thank you, and have a great day.
17:15 to 32:50 · One card per analyst, follow-ups included. Each plays from its start, and the one being answered is marked.
Thank you, management, for the very detailed explanation for the quarter results. So I have two questions. So the first question is about how does management balance The M&A strategy with the capital allocation strategy, I think that the reason I asked this question was because in the short term, the M&A strategy could…
Sam Tsang: Thank you very much, Christine, for your question. So the first one is about the balance between our M&A strategy and also our shareholder report program. And the second one is about the export rebate, what will happen on our financials. So regarding the first…
Hi, management. This is Lydia from Citi. So I have two questions. My first question is about international expansion. So with the consolidation of the newly acquired EU entity, so what would be your outlook for the international expansion for 2027? And also, specifically, could you share with us some details in that…
Sam Tsang: Thanks, Lydia, for our question. So the first one is on the growth trajectory of our company, and the second one is on our M&A pipelines. So if Shenzhen hosting APEC this week, under the themes of openness, innovation, and regional cooperation, the world is…
This is Zoe from CICC. I have two questions about the international markets. First, as for the Southeast Asia, what is your strategy for the SEA market going forward? And we know that in second quarter, there are some relations. And what's your current situation in this market? And next, about the European market…
Sam Tsang: Thank you, Sui, for your questions. So, I mean, across Southeast Asia, RX holds a number one market leadership in multiple key countries, anchored by strong brand equity and deep consumer trust. We see tremendous long-term runway across the region, supported…
My question is that regarding the EUC's plan to implement an illiquid tax, how do you evaluate the potential impact on both the industry and the company, and what is the company's strategy to navigate this change?
Sam Tsang: Thank you very much, Guoyun, for your questions. As the vaping prior duty got effective in October this year, there have been a six-month of transitional period from October this year to March next year. We are seeing a growing number of distributors and…
SEC call announcement
Filed Nov 20, 2026 · complete as-filed document